Internal Medicine, Gastroenterology · Los Angeles, CA
NPI
1114054046
Since 2007
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
8631 W 3rd St, Suite 540e
Los Angeles, CA, 90048
Phone (310) 659-9600
Groups this clinician bills Medicare through
Medicare paid, 2024
$165K
1,578 services
Medicare patients, 2024
682
Average age 76
Drug cost, 2024
$508K
2,505 prescriptions
Company payments, 2025
$2,069
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jeffrey H Sherman was code 99214 (office e&m - established), 642 times for 411 patients. In total Jeffrey H Sherman billed 1,578 services in 17 codes, and Medicare paid $165K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 642 | 411 | $97.90 | $63K |
| 43239 Upper GI Endoscopy | Facility | 214 | 211 | $72.83 | $16K |
| 99213 Office E&M - Established | Office | 177 | 117 | $67.74 | $12K |
| 99204 Office E&M - New | Office | 139 | 139 | $125.13 | $17K |
| 45378 Lower GI Endoscopy - Other | Facility | 121 | 120 | $134.27 | $16K |
| 45385 Colonoscopy - Lesion Removal | Facility | 96 | 96 | $185.64 | $18K |
| 99205 Office E&M - New | Office | 60 | 60 | $138.43 | $8,306 |
| 99215 Office E&M - Established | Office | 46 | 41 | $129.14 | $5,940 |
| 45380 Lower GI Endoscopy - Other | Facility | 37 | 37 | $137.80 | $5,099 |
| 45331 Lower GI Endoscopy - Other | Facility | 15 | 15 | $51.09 | $766 |
By year: 2022 $156K for 1,426 services; 2023 $162K for 1,323 services; 2024 $165K for 1,578 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jeffrey H Sherman prescribed most often to Medicare patients was Famotidine, with 495 prescriptions and refills. In total Jeffrey H Sherman wrote 2,505 Medicare prescriptions that cost $508K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Famotidine Generic | 495 | 916 | 144 | $6,449 |
| Pantoprazole Sodium Generic | 484 | 868 | 123 | $4,729 |
| Clenpiq Sod Picosulf/Mag Ox/Citric Ac | 144 | 144 | 139 | $25K |
| Neomycin Sulfate Generic | 89 | 89 | 58 | $2,008 |
| Sucralfate Generic | 86 | 92 | 24 | $3,818 |
| Dicyclomine Hcl Generic | 79 | 89 | 37 | $1,001 |
| Esomeprazole Magnesium Generic | 66 | 118 | 14 | $4,523 |
| Metoclopramide Hcl Generic | 59 | 61 | 16 | $173 |
| Dexlansoprazole Dr Dexlansoprazole | 59 | 105 | 13 | $14K |
| Xifaxan Rifaximin | 58 | 58 | 35 | $121K |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 44 | 55 | 42 | $2,897 |
| Omeprazole Generic | 42 | 75 | 21 | $466 |
| Mesalamine Generic | 39 | 49 | Under 11 | $14K |
| Ondansetron Hcl Generic | 39 | 40 | Under 11 | $245 |
| Creon Lipase/Protease/Amylase | 36 | 40 | Under 11 | $58K |
Brand drugs: - claims; generic drugs: 2,066 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jeffrey H Sherman $2,069 ($2,069 in general payments such as food, travel and fees) from 17 companies. The largest payer was Salix Pharmaceuticals, a division of Bausch Health US, LLC with $472.
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 27 | $472 |
| Abbvie Inc. ABBV | 24 | $437 |
| Janssen Biotech, Inc. JNJ | 15 | $314 |
| Ardelyx, Inc. ARDX | 5 | $144 |
| Phathom Pharmaceuticals, Inc. PHAT | 5 | $127 |
| Genzyme Corporation SNY | 3 | $102 |
| QOL Medical, LLC | 3 | $92.42 |
| Aimmune Therapeutics, Inc. | 3 | $86.3 |
| Regeneron Healthcare Solutions, Inc. REGN | 2 | $60.59 |
| Novo Nordisk Inc NVO | 2 | $51.43 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.